Inventage Lab, Inc. (KOSDAQ:389470)
South Korea · Delayed Price · Currency is KRW 30,250
+150 (0.50%)
At close: Aug 20, 2026
Inventage Lab Market Cap
Inventage Lab has a market cap or net worth of 401.64 billion as of August 20, 2026. Its market cap has increased by 13.61% in one year.
Market Cap
401.64B
Enterprise Value
373.25B
Revenue
3.16B
Ranking
n/a
PE Ratio
134.21
Stock Price
30,250.00
ChartMarket Cap Chart
Since November 22, 2022, Inventage Lab's market cap has increased from 122.67B to 401.64B, an increase of 227.41%. That is a compound annual growth rate of 37.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 401.64B | -61.80% |
| Dec 30, 2025 | 1.05T | 391.67% |
| Dec 30, 2024 | 213.83B | 45.37% |
| Dec 28, 2023 | 147.09B | 83.30% |
| Dec 29, 2022 | 80.25B | -34.58% |
| Nov 22, 2022 | 122.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 724.87B |
| ROKIT Healthcare | 522.67B |
| Curocell | 374.59B |
| IntoCell | 314.71B |
| HansBiomed | 293.07B |
| IMBiologics | 256.11B |
| Kangstem Biotech | 242.66B |
| S.Biomedics | 238.91B |